CRISPR Therapeutics to Present Clinical Data on Zugocabtagene Geleucel in Autoimmune Disease at the American College of Rheumatology Convergence 2026 02 October
CRISPR Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference 08 September
CRISPR Therapeutics Presents Phase 1a Data for CTX310® Demonstrating Deep and Durable ANGPTL3 Editing, Triglyceride and LDL Lowering at ESC Congress 2026 28 August
